Publications by authors named "Valentina Stolzlechner"
Article Synopsis
- A study at Innsbruck University Hospital analyzed 259 Binet A stage CLL patients from 2000-2022, highlighting that 16.9% had chronic kidney disease, with median overall survival similar across patient groups.
- The research found B2M levels were higher in CKD patients, yet remained a key factor influencing overall survival, suggesting it could improve future risk models in CLL, especially with current treatment options.
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults and characterized by a highly heterogeneous clinical course. The CLL-IPI and the OCLL-1 scores are among the best validated tools to predict time-to-first-treatment. In both models, elevated beta-2-microglobulin plasma level (B2M) is an independent prognostic factor.
View Article and Find Full Text PDF